These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11117432)

  • 1. A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancy.
    Krugluger W; Festa A; Shnawa N; Bucher J; Boltz-Nitulescu G; Schernthaner G; Hopmeier P
    J Inherit Metab Dis; 2000 Nov; 23(7):705-12. PubMed ID: 11117432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene.
    Weisnagel SJ; Rankinen T; Nadeau A; Rao DC; Chagnon YC; Pérusse L; Bouchard C
    Diabetes; 2001 Mar; 50(3):697-702. PubMed ID: 11246895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms.
    Nikolac N; Simundic AM; Katalinic D; Topic E; Cipak A; Zjacic Rotkvic V
    Arch Med Res; 2009 Jul; 40(5):387-92. PubMed ID: 19766903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.
    Ammälä C; Moorhouse A; Gribble F; Ashfield R; Proks P; Smith PA; Sakura H; Coles B; Ashcroft SJ; Ashcroft FM
    Nature; 1996 Feb; 379(6565):545-8. PubMed ID: 8596634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.
    Inoue H; Ferrer J; Welling CM; Elbein SC; Hoffman M; Mayorga R; Warren-Perry M; Zhang Y; Millns H; Turner R; Province M; Bryan J; Permutt MA; Aguilar-Bryan L
    Diabetes; 1996 Jun; 45(6):825-31. PubMed ID: 8635661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia.
    Goksel DL; Fischbach K; Duggirala R; Mitchell BD; Aguilar-Bryan L; Blangero J; Stern MP; O'Connell P
    Hum Genet; 1998 Sep; 103(3):280-5. PubMed ID: 9799081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor.
    Katz LE; Ferry RJ; Stanley CA; Collett-Solberg PF; Baker L; Cohen P
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3117-24. PubMed ID: 10487673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The common C49620T polymorphism in the sulfonylurea receptor gene SUR1 (ABCC8) in patients with gestational diabetes and subsequent glucose metabolism abnormalities.
    Molęda P; Bińczak-Kuleta A; Homa K; Safranow K; Celewicz Z; Syrenicz A; Stefański A; Fronczyk A; Majkowska L
    Exp Diabetes Res; 2012; 2012():712617. PubMed ID: 22927833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
    Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O
    Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM.
    Hansen L; Echwald SM; Hansen T; Urhammer SA; Clausen JO; Pedersen O
    Diabetes; 1997 Mar; 46(3):508-12. PubMed ID: 9032110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pas de deux or more: the sulfonylurea receptor and K+ channels.
    Philipson LH; Steiner DF
    Science; 1995 Apr; 268(5209):372-3. PubMed ID: 7716539
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
    Gonen MS; Arikoglu H; Erkoc Kaya D; Ozdemir H; Ipekci SH; Arslan A; Kayis SA; Gogebakan B
    Arch Med Res; 2012 May; 43(4):317-23. PubMed ID: 22704848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine diphosphate as an intracellular regulator of insulin secretion.
    Nichols CG; Shyng SL; Nestorowicz A; Glaser B; Clement JP; Gonzalez G; Aguilar-Bryan L; Permutt MA; Bryan J
    Science; 1996 Jun; 272(5269):1785-7. PubMed ID: 8650576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.